Takeda Pharmaceutical Co. Ltd.

Plus: Jon Garay Alonso named CFO of Almirall, and updates from Certara and Immunai

Bright spot was a slight rise in Protagonist shares on polycythemia vera results

Plus: Hummingbird/Callio, Bridgene/Takeda, Magnet/Lilly, Gensaic/Novo, and more

Plus: Jeffrey Sevigny named CMO of Rapport, and updates from Garuda, Metis, Ovid and more

As the first Dravet syndrome products establish the market, the pipeline moves toward selective small molecules and genetic therapies

Plus: Paul Hitchin succeeds Laetitia Rouxel as CFO of Evotec, and updates from Elekta, Forx, Abzena and more

Plus: New chair at Outlook and an update from Elevation

Plus: Roche hires a chief digital technology officer, and updates from Gain, Allogene, Airna, Osta and more

Califf, Gottlieb, McClellan, Woodcock advise the next commissioner to collaborate with staff, push change to keep up with scientific advances

An analysis of $1B+ takeouts in 2016-24 finds biotechs opting for the billion dollar exit door in robust numbers